A meta-analysis comparing clinical characteristics and outcomes in CALR-mutated and JAK2V617F essential thrombocythaemia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A meta-analysis comparing clinical characteristics and outcomes in CALR-mutated and JAK2V617F essential thrombocythaemia
Authors
Keywords
Calreticulin, JAK2V617F, Essential thrombocythaemia, Meta-analysis
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 101, Issue 2, Pages 165-172
Publisher
Springer Nature
Online
2014-12-24
DOI
10.1007/s12185-014-1724-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients
- (2014) Ayalew Tefferi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia
- (2014) Chih-Cheng Chen et al. ANNALS OF HEMATOLOGY
- JAK2V617F andCALRmutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort
- (2014) Gillian McGaffin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history
- (2014) Naseema Gangat et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients
- (2014) C. Qiao et al. HAEMATOLOGICA
- Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations
- (2014) H. Andrikovics et al. HAEMATOLOGICA
- Calreticulin mutations and long-term survival in essential thrombocythemia
- (2014) A Tefferi et al. LEUKEMIA
- Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: clinical implications in diagnosis, prognosis and treatment
- (2014) R Fu et al. LEUKEMIA
- An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
- (2014) A Tefferi et al. LEUKEMIA
- CALRandASXL1mutation analysis in 190 patients with essential thrombocythemia
- (2014) Hongjie Shen et al. LEUKEMIA & LYMPHOMA
- Interferon Alfa Therapy in CALR-Mutated Essential Thrombocythemia
- (2014) Bruno Cassinat et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia
- (2013) G. Rotunno et al. BLOOD
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
- (2013) E. Rumi et al. BLOOD
- Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
- (2013) J. Nangalia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
- (2013) Thorsten Klampfl et al. NEW ENGLAND JOURNAL OF MEDICINE
- New mutations and pathogenesis of myeloproliferative neoplasms
- (2011) W. Vainchenker et al. BLOOD
- Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
- (2011) A. Carobbio et al. BLOOD
- The 2008 World Health Organization classification system for myeloproliferative neoplasms
- (2009) Ayalew Tefferi et al. CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now